Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

The Lancet Oncology
Michael GnantAustrian Breast and Colorectal Cancer Study Group (ABCSG)

Abstract

The Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) bone substudy assesses zoledronic acid for preventing bone loss associated with adjuvant endocrine therapy and reports on long-term findings of bone-mineral density (BMD) during 3 years of treatment and 2 years after completing adjuvant treatment with or without zoledronic acid. The aim of this substudy is to gain insight into bone health in this setting. ABCSG-12 is a randomised, open-label, phase III, 4-arm trial comparing tamoxifen (20 mg/day orally) and goserelin (3.6 mg subcutaneously every 28 days) versus anastrozole (1 mg/day orally) and goserelin (3.6 mg subcutaneously every 28 days), both with or without zoledronic acid (4 mg intravenously every 6 months) for 3 years in premenopausal women with endocrine-responsive breast cancer. This prospective bone subprotocol measured BMD at 0, 6, 12, 36, and 60 months. The primary endpoint of the bone substudy (secondary endpoint in the main trial) was change in BMD at 12 months, assessed by dual-energy X-ray absorptiometry in assessable patients. Analyses were intention to treat. Statistical significance was assessed by t tests. The ABCSG-12 trial is registered on the ClinicalTrials.gov website, number NCT0...Continue Reading

References

Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W JonatJ F Forbes
Feb 16, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Aug 9, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C J HernandezD R Carter
Oct 8, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I FogelmanW Wilpshaar
May 26, 2004·Archives of Internal Medicine·Ethel S SirisMarc L Berger
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SverrisdóttirL E Rutqvist
Apr 8, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Alan W Friedman
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam BrufskyEdith A Perez
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael F X GnantUNKNOWN Austrian Breast and Colorectal Cancer Study Group
Aug 1, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sundeep KhoslaUNKNOWN American Society for Bone and Mineral Research
Aug 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN 10th St. Gallen conference

❮ Previous
Next ❯

Citations

Jun 2, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lale AtahanMutlu Hayran
May 18, 2010·Wiener medizinische Wochenschrift·Michael HubalekChristian Marth
Dec 23, 2008·Breast Cancer Research and Treatment·Joseph Gligorov, Jean-Pierre Lotz
May 22, 2010·Breast Cancer Research and Treatment·Allan Lipton
Aug 11, 2010·Breast Cancer Research and Treatment·Charles L Shapiro
Oct 12, 2011·Breast Cancer Research and Treatment·Dulcinea Candelaria-QuintanaMelanie E Royce
Mar 22, 2012·Breast Cancer Research and Treatment·Daniel Prieto-AlhambraXavier Nogues
Sep 3, 2011·Current Treatment Options in Oncology·Keo Tabane, Daniel A Vorobiof
Jul 24, 2013·Current Osteoporosis Reports·Matthew T Drake
Dec 6, 2012·Pathology Oncology Research : POR·Orsolya Rusz, Zsuzsanna Kahán
Jan 1, 2012·BoneKEy Reports·Jean-Jacques Body
Dec 10, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Robert E Coleman
Feb 14, 2009·The New England Journal of Medicine·Michael GnantC Marth
Mar 7, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K OkamotoK Nakagawa
May 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H EidtmannR Coleman
Jul 10, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P E Lønning
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J Body
Mar 14, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F NuzzoF Perrone
Oct 11, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ColemanN Bundred
Oct 25, 2011·Journal of the National Cancer Institute·Genevieve M MonseesChristopher I Li
Feb 22, 2013·Journal of the National Cancer Institute·Michael GnantKathleen I Pritchard
Sep 5, 2009·Current Opinion in Oncology·Matthew C Winter, Robert E Coleman
Oct 9, 2012·Current Opinion in Oncology·Michael Gnant
Oct 2, 2012·Therapeutic Advances in Urology·Peter F Mulders
Nov 1, 2009·Therapeutic Advances in Medical Oncology·Michael GnantRaimund Jakesz
Nov 12, 2010·Breast Cancer Research : BCR·Courtney A Gabriel, Susan M Domchek
Dec 22, 2010·Breast Cancer Research : BCR·Michael Gnant, Peyman Hadji
Apr 30, 2013·Endocrine-related Cancer·Per Eystein Lønning, Hans Petter Eikesdal
May 16, 2009·Endocrine-related Cancer·Larry J SuvaIssam Makhoul
Dec 15, 2010·Drug Design, Development and Therapy·Ronald C Hamdy
Nov 16, 2012·International Journal of Women's Health·Rebecca Aft
Jan 1, 2009·OncoTargets and Therapy·Michael Gnant
Dec 20, 2008·Drugs·Katherine A Lyseng-Williamson
Feb 8, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P HadjiM Bauer
May 8, 2013·Future Oncology·Robin J Young, Robert E Coleman
Oct 9, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chin-Sheng HungYu-Jia Chang
Jan 25, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R RizzoliUNKNOWN European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.